Methylbenzylzinc bromide solution

Product Information

Molecular Formula:
C6H5CH(CH3)ZnBr
Molecular Weight:
250.45
Description
Methylbenzylzinc bromide solution is a valuable reagent used in the biomedical industry. It finds application in the synthesis of various organic compounds and pharmaceutical drugs. This solution is particularly utilized in the development of drugs to treat diseases such as cancer, cardiovascular disorders, and neurological conditions. Methylbenzylzinc bromide solution serves as a crucial building block in the production of novel therapies contributing to advancements in biomedicine.
Synonyms
A-METHYLBENZYLZINC BROMIDE; a-Methylbenzylzinc bromide 0.5 M in Tetrahydrofuran; bromozinc(1+); ethylbenzene; alpha-methylbenzyl zinc bromide
IUPAC Name
bromozinc(1+)ethylbenzene
Canonical SMILES
C[CH-]C1=CC=CC=C1.[Zn+]Br
InChI
InChI=1S/C8H9.BrH.Zn/c1-2-8-6-4-3-5-7-8/h2-7H,1H31H/q-1+2/p-1
InChI Key
LCPVHNNFHPWFCI-UHFFFAOYSA-M
Flash Point
1.4 °F - closed cup
Density
0.965 g/mL at 25 °C
Storage
2-8°C

Safety Information

Hazards
H225 - H261 - H302 - H319 - H335 - H351
Precautionary Statement
P210 - P231 + P232 - P280 - P370 + P378 - P402 + P404 - P403 + P235

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
1
Exact Mass
247.91790 g/mol
Monoisotopic Mass
247.91790 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
60.3
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
US-2007037824-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-2007054906-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-2007054925-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-2007225270-A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-2007281951-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-2008050384-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-7161003-B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
US-7807683-B2 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors 2002-09-04
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket